• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Radiology AI Marketplace CARPL Secures $6M to Bridge Radiologist Gap with Seamless Integration Tools

Share:

February 6, 2024

CARPL, an enterprise imaging AI marketplace, has raised $6 million in funding to streamline the integration of AI tools into radiology workflows. With numerous AI solutions available, CARPL offers a single platform for AI discovery, validation, and deployment in healthcare settings. Their DEV-D framework allows healthcare providers to explore AI applications, validate them through rigorous testing, and seamlessly deploy them in clinical workflows. CARPL envisions AI democratizing radiology, empowering radiologists to handle more cases with improved accuracy, and improving access to quality diagnostics for patients worldwide. The funding will be used to expand the North American team and develop the technology platform.

As healthcare demands rise with an aging population and growing emphasis on early disease detection, the burden on radiologists is reaching a critical point. To address this challenge, enterprise imaging AI marketplace platform CARPL has announced a $6M funding round, aiming to bridge the radiologist gap by streamlining access and integration of AI tools into clinical workflows.

Navigating the Maze of AI Solutions

With over 200 companies developing AI applications for radiologists and 700 FDA-approved solutions already available, healthcare providers face a daunting task: selecting the right AI for their specific needs and seamlessly integrating it into their existing systems. This complexity has hampered AI adoption in healthcare, despite its potential to enhance efficiency and accuracy.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

CARPL’s Solution: A Single Platform for AI Discovery, Validation, and Deployment

CARPL’s proprietary DEV-D framework offers a unique solution. Healthcare providers can Discover (D) and Explore (E) various AI applications from CARPL’s marketplace, then Validate (V) them through its rigorous testing procedures. Finally, the platform facilitates seamless Deployment (D) of the chosen AI across clinical workflows.

CARPL goes beyond simply connecting providers with AI solutions. Its deep validation and monitoring capabilities ensure safe and effective implementation, prioritizing patient safety and data privacy. Additionally, the platform’s universal AI viewer acts as a single interface for radiologists, allowing them to interact with AI outputs and refine results, further improving the AI’s performance over time.

Leadership Team

Founded by Dr. Vidur Mahajan, a physician with extensive experience in the diagnostics industry, CARPL is led by a team of experts including Dr. Vasanth Venugopal (Chief Medical Officer), Rohit Takhar (CTO), and Dhruv Sahai (COO). Dr. Vijay Rao, a past president of the Radiology Society of North America, has also joined their advisory team, further solidifying their commitment to innovation and collaboration.

The Future: Democratizing Radiology and Empowering Radiologists

Drawing inspiration from the automation revolution in lab medicine, CARPL envisions a future where AI empowers radiologists, making them “super-radiologists” capable of handling significantly more cases with improved accuracy. This democratization of radiology has the potential to improve access to quality diagnostics for patients worldwide.

Expansion Plans

CARPL plans to utilize the new funding to expand its North American team and further develop its technology platform. With partnerships with leading healthcare organizations like Massachusetts General Hospital and government initiatives in India, CARPL is poised to make a significant impact on the future of radiology and patient care.

“Over the past two years, we have onboarded more than 50 AI developers having 100+ AI applications, which made us the largest AI marketplace in terms of number of AI applications offered to customers. We are proud that some of the largest healthcare enterprises in the world have vetted our technology and trust us to be their partner in their AI and automation journeys.” said Dr Vidur Mahajan, CEO of CARPL. Drawing parallels with the lab medicine industry, Vidur Mahajan added: “We are democratizing radiology in the same way that automation and robotics revolutionized lab medicine, where a single pathologist signs out thousands of tests each day. We envision a future where CARPL creates ‘super-radiologists’ – AI-enabled radiologists who are ten times more productive than traditional radiologists.” Vidur Mahajan brings deep domain expertise having previously grown revenue 10x to $20m in 10 years at his family business Mahajan Imaging, a leading radiology service provider. He conceptualized CARPL under the guidance of his father Dr Harsh Mahajan, a pioneer in radiology, while working on validation and deployment of AI at Mahajan Imaging.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Research: Half of Hospital Leaders Plan to Invest in AI by 2021Research: Half of Hospital Leaders Plan to Invest in AI by 2021
  • Protalix BioTherapeutics Announces Closing of $43.7 Million Private PlacementProtalix BioTherapeutics Announces Closing of $43.7 Million Private Placement
  • 9 recent healthcare partnerships and transactions9 recent healthcare partnerships and transactions
  • Accelerator Life Science Partners’ Portfolio Company Lodo Therapeutics Acquired By Zymergen Inc.Accelerator Life Science Partners’ Portfolio Company Lodo Therapeutics Acquired By Zymergen Inc.
  • Agiliti Acquires Zetta Medical TechnologiesAgiliti Acquires Zetta Medical Technologies
  • Mayo Initiative Shows AI Can Detect Irregular Heart RhythmsMayo Initiative Shows AI Can Detect Irregular Heart Rhythms
  • Pacific Bio Shares Fall on U.K. Antitrust Concern About Illumina DealPacific Bio Shares Fall on U.K. Antitrust Concern About Illumina Deal
  • Tandem Diabetes Care Acquires Sugarmate, a Popular Mobile App for People with DiabetesTandem Diabetes Care Acquires Sugarmate, a Popular Mobile App for People with Diabetes

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications